BioCentury | Oct 26, 2018
Financial News

Antibiotics play Qpex launches with Medicines Co. assets, BARDA deal

...Both were also executives at Mpex Pharmaceuticals Inc., which Axcan Pharma Inc. acquired in 2011; Axcan...
BioCentury | Oct 26, 2018
Finance

Rempex remix

...also executives at anti-infectives company Mpex Pharmaceuticals Inc., which Axcan Pharma Inc. acquired in 2011; Axcan...
BioCentury | Oct 22, 2018
Financial News

Antibiotics play Qpex launches with Medicines Co. assets, BARDA deal

...Both were also executives at Mpex Pharmaceuticals Inc., which Axcan Pharma Inc. acquired in 2011; Axcan...
BioCentury | Apr 3, 2015
Financial News

Financial tracks

...an operating executive on its growth buyout team. Maroun was SVP and general counsel at Aptalis Holdings...
BioCentury | Feb 14, 2015
Company News

TPG regains Aptalis unit from Actavis

...and allow customized drug release. Forest Laboratories Inc. , acquired by Actavis last year, purchased Aptalis Holdings Inc....
BioCentury | Dec 8, 2014
Company News

Cortendo management update

...Gothenburg, Sweden Business: Endocrine/Metabolic Hired: Ruth Thieroff-Ekerdt as CMO, effective Dec. 15, formerly CMO of Aptalis Pharma...
BioCentury | Apr 28, 2014
Company News

Lupin management update

...global operations, formerly chief corporate development officer for M&A, strategy and global business development at Aptalis Holdings Inc....
BioCentury | Mar 17, 2014
Company News

Synergy management update

...SVP of corporate development, a newly created position, formerly VP of global business development at Aptalis Holdings Inc....
BioCentury | Feb 24, 2014
Finance

Tree hugging

...of $150 million for the 12 months ended September 2013. As a follow-up, Forest acquired Aptalis Holdings Inc....
BioCentury | Feb 24, 2014
Company News

Actavis, Forest Laboratories deal

...unveiled a host of new initiatives, including this month's $2.9 billion acquisition of gastrointestinal company Aptalis Holdings Inc....
Items per page:
1 - 10 of 341
BioCentury | Oct 26, 2018
Financial News

Antibiotics play Qpex launches with Medicines Co. assets, BARDA deal

...Both were also executives at Mpex Pharmaceuticals Inc., which Axcan Pharma Inc. acquired in 2011; Axcan...
BioCentury | Oct 26, 2018
Finance

Rempex remix

...also executives at anti-infectives company Mpex Pharmaceuticals Inc., which Axcan Pharma Inc. acquired in 2011; Axcan...
BioCentury | Oct 22, 2018
Financial News

Antibiotics play Qpex launches with Medicines Co. assets, BARDA deal

...Both were also executives at Mpex Pharmaceuticals Inc., which Axcan Pharma Inc. acquired in 2011; Axcan...
BioCentury | Apr 3, 2015
Financial News

Financial tracks

...an operating executive on its growth buyout team. Maroun was SVP and general counsel at Aptalis Holdings...
BioCentury | Feb 14, 2015
Company News

TPG regains Aptalis unit from Actavis

...and allow customized drug release. Forest Laboratories Inc. , acquired by Actavis last year, purchased Aptalis Holdings Inc....
BioCentury | Dec 8, 2014
Company News

Cortendo management update

...Gothenburg, Sweden Business: Endocrine/Metabolic Hired: Ruth Thieroff-Ekerdt as CMO, effective Dec. 15, formerly CMO of Aptalis Pharma...
BioCentury | Apr 28, 2014
Company News

Lupin management update

...global operations, formerly chief corporate development officer for M&A, strategy and global business development at Aptalis Holdings Inc....
BioCentury | Mar 17, 2014
Company News

Synergy management update

...SVP of corporate development, a newly created position, formerly VP of global business development at Aptalis Holdings Inc....
BioCentury | Feb 24, 2014
Finance

Tree hugging

...of $150 million for the 12 months ended September 2013. As a follow-up, Forest acquired Aptalis Holdings Inc....
BioCentury | Feb 24, 2014
Company News

Actavis, Forest Laboratories deal

...unveiled a host of new initiatives, including this month's $2.9 billion acquisition of gastrointestinal company Aptalis Holdings Inc....
Items per page:
1 - 10 of 341